The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2013

Filed:

Jul. 03, 2009
Applicants:

Romain Bernard, Paris, FR;

Bénédicte Dupas, Paris, FR;

Alain Gaudric, Paris, FR;

Serge Picaud, Paris, FR;

Alvaro Rendon, Paris, FR;

José-alain Sahel, Paris, FR;

Abdoulaye Sene, Paris, FR;

Florian Sennlaub, Paris, FR;

Ramin Tadayoni, Paris, FR;

Eric Vicaut, Paris Cedex, FR;

Inventors:

Romain Bernard, Paris, FR;

Bénédicte Dupas, Paris, FR;

Alain Gaudric, Paris, FR;

Serge Picaud, Paris, FR;

Alvaro Rendon, Paris, FR;

José-Alain Sahel, Paris, FR;

Abdoulaye Sene, Paris, FR;

Florian Sennlaub, Paris, FR;

Ramin Tadayoni, Paris, FR;

Eric Vicaut, Paris Cedex, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention shows the implication of Dp71 in angiogenesis and thus provides novel therapeutic approaches, as well as novel methods for screening agents modulating angiogenesis, which target this protein. More specifically, the present invention relates to the use of Dp71 or a variant thereof (or a coding nucleic acid) for stimulating angiogenesis in a subject, particularly a human subject. The invention relates to the use of an inhibitor of Dp71 for inhibiting angiogenesis in a subject.


Find Patent Forward Citations

Loading…